Literature DB >> 7504476

Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions.

K L MacNaul1, N I Hutchinson.   

Abstract

To examine the potential contribution of endothelial cell cNOS (ec-cNOS) and inducible NOS (iNOS) in controlling vascular tone under normal versus inflammatory conditions, we performed Northern hybridizations to examine the differential expression of each NOS mRNA in human aortic endothelial cells (AOEC) and human aortic smooth muscle cells (AOSMC) cultured for 8 h in the presence or absence of cytokines (IL-1 beta, TNF-alpha, and IFN-gamma) and LPS. Cytokine/LPS treatment induced a 4.4 kb iNOS mRNA in the human AOSMC; in contrast, cytokine/LPS treatment down regulated the expression of ec-cNOS mRNA in the AOEC. No iNOS mRNA was detected in the AOEC under the conditions examined. These results suggest that under specific inflammatory conditions the generation of NO in vascular tissue switches from ec-cNOS in the endothelium to iNOS in the smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504476     DOI: 10.1006/bbrc.1993.2398

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

1.  Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells.

Authors:  H Bauer; T Jung; D Tsikas; D O Stichtenoth; J C Frölich; C Neumann
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 2.  The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death.

Authors:  Ping Qiu; Xizhong Cui; Amisha Barochia; Yan Li; Charles Natanson; Peter Q Eichacker
Journal:  Expert Opin Investig Drugs       Date:  2011-10-01       Impact factor: 6.206

3.  Lipopolysaccharide and interleukin 1 augment the effects of hypoxia and inflammation in human pulmonary arterial tissue.

Authors:  R Ziesche; V Petkov; J Williams; S M Zakeri; W Mosgöller; M Knöfler; L H Block
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

Review 4.  The role of nitric oxide in sepsis and ARDS: synopsis of a roundtable conference held in Brussels on 18-20 March 1995.

Authors:  M P Fink; D Payen
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

5.  Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis.

Authors:  Norihiko Takeda; Ellen L O'Dea; Andrew Doedens; Jung-whan Kim; Alexander Weidemann; Christian Stockmann; Masataka Asagiri; M Celeste Simon; Alexander Hoffmann; Randall S Johnson
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

Review 6.  Nitric oxide and redox mechanisms in the immune response.

Authors:  David A Wink; Harry B Hines; Robert Y S Cheng; Christopher H Switzer; Wilmarie Flores-Santana; Michael P Vitek; Lisa A Ridnour; Carol A Colton
Journal:  J Leukoc Biol       Date:  2011-01-13       Impact factor: 4.962

Review 7.  Methylene blue for distributive shock: a potential new use of an old antidote.

Authors:  David H Jang; Lewis S Nelson; Robert S Hoffman
Journal:  J Med Toxicol       Date:  2013-09

8.  Increased nitric oxide activity in a rat model of acute pancreatitis.

Authors:  R A Al-Mufti; R C Williamson; R T Mathie
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

9.  All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.

Authors:  Abdelrahman M Elsayed; Tamer M Abdelghany; El-Sayed Akool; Abdel-Aziz H Abdel-Aziz; Mohamed S Abdel-Bakky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-11       Impact factor: 3.000

10.  Neurodegeneration and glia response in rat hippocampus following nitro-L-arginine methyl ester (L-NAME).

Authors:  G J Harry; R Sills; M J Schlosser; W E Maier
Journal:  Neurotox Res       Date:  2001-07       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.